Compare Okta, Inc. (OKTA) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Okta, Inc. vs 10X Genomics Inc — how do they compare? Okta, Inc. trades at $136.54 (market cap $24.63B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Okta, Inc. is far larger — about 4.5× 10X Genomics Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Okta, Inc. nearer its low. Which is the better fit depends on your goals.
| OKTA | TXG | |
|---|---|---|
Market Cap | $24.63B | $5.48B |
Sector | Technology | Health |
52-Week High | $154.62 | $47.20 |
52-Week Low | $62.93 | $11.34 |
Enterprise Value | $22.45B | $5.02B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Okta, Inc.
Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.
Read more on OKTA →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
